gold has been researched along with Infections, Respiratory Syncytial Virus in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blum, DL; Crowe, JE; Kuhn, SJ; Stone, JW; Thornburg, NJ; Wright, DW | 1 |
Gao, PF; Huang, CZ; Li, CM; Li, YF; Wan, XY; Yang, XX; Zheng, LL | 1 |
Bawage, SS; Dennis, VA; Dixit, S; Pillai, SR; Singh, A; Singh, SR; Tiwari, PM | 1 |
3 other study(ies) available for gold and Infections, Respiratory Syncytial Virus
Article | Year |
---|---|
Gold nanorod vaccine for respiratory syncytial virus.
Topics: Aged, 80 and over; Antigens, Viral; Cells, Cultured; Gold; Humans; Immobilized Proteins; Infant, Newborn; Nanotubes; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; T-Lymphocytes | 2013 |
Real-time light scattering tracking of gold nanoparticles- bioconjugated respiratory syncytial virus infecting HEp-2 cells.
Topics: Biotin; Cell Line, Tumor; Gold; Humans; Metal Nanoparticles; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Signal-To-Noise Ratio; Streptavidin | 2014 |
Gold nanorods inhibit respiratory syncytial virus by stimulating the innate immune response.
Topics: Animals; Gold; Humans; Immunity, Innate; Mice; Mice, Inbred NOD; Nanotubes; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses | 2016 |